European Medicines Agency (EMA) Validates Henlius and Organon Filings for Prolia® and Xgeva® (Denosumab) Biosimilar Candidate Hlx14
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.